Pancreatic Neuroendocrine Tumor (NETs) Diagnostic Testing
Providing continuity of service for rare Endocrinology and Gastroenterology testing since 1969
is still the hallmark of Inter Science Institute.
On November 19th, Inter Science Institute’s C.O.O., Mia S. Tepper, MBA was the featured speaker on the Carcinoid Cancer Foundation “Luncheon with the Experts”.
Click this link to view the video.
The Carcinoid Cancer Foundation began as the Carcinoid Tumor and Serotonin Research Foundation in 1968 when the NIH fund for rare cancers was terminated. The name was changed to the Carcinoid Cancer Foundation in 1995. It is a nonprofit organization chartered by the State of New York for the purpose of encouraging and supporting education and research on carcinoid and related neuroendocrine cancers. For more information go to: www.carcinoid.org.
To learn more about how these biomarkers are used, read the paper(s) below:
The C.U.R.E.® Catalogue lists over 150 individual assays, that can be performed on plasma/serum, urine, CSF, Saliva, and other fluids in the areas of:
Please contact ISI for the most up-to-date testing availability.
Updated with ICD-10 codes
Since 1969, our cutting-edge esoteric services to the medical, research, and academic communities, Inter Science Institute specializes in research and development emphasis in the area of Neuroendocrine Tumors (NET’s). The current 5th edition handbook, Neuroendocrine Tumors: A Comprehensive Guide to Diagnosis and Management, is available for download on this website or by contacting ISI at email@example.com.